Antioxidant effect of immediate- versus sustained-release melatonin in type 2 diabetes mellitus and healthy controls

References

• Beers RF, Sizer IW. (1952). A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195:133–40
   PubMed Web of Science ®Google Scholar
• Benot S, Goberna R, Reiter RJ, et al. (1999). Physiological levels of melatonin contribute to the antioxidant capacity of human serum. J Pineal Res 27:59–64
   PubMed Web of Science ®Google Scholar
• Beutler E. (1971). Red cell metabolism. In: Beutler E, ed. A manual of biochemical methods. New York (NY): Grune-Stratton, 11–12
   Google Scholar
• Cardinali DP, Furio AM, Brusco LI. (2010). Clinical aspects of melatonin intervention in Alzheimer’s disease progression. Curr Neuropharmacol 8:218–27
   PubMed Web of Science ®Google Scholar
• Circadin, (2014). INN-melatonin – WC500026811.pdf. Available from: Source://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Product_Information/human/000695/WC500026811.pdf [last accessed 17 Apr 2014]
   Google Scholar
• Colak E, Majkić-Singh N, Stanković S, et al. (2005). Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications. Ann Med 37:613–20
   PubMed Web of Science ®Google Scholar
• Erşahin M, Sehirli O, Toklu HZ, et al. (2009). Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension. J Pineal Res 47:97–106
   PubMed Web of Science ®Google Scholar
• Fardoun RZ. (2007). The use of vitamin E in type 2 diabetes mellitus. Clin Exp Hypertens 29:135–48
   PubMed Web of Science ®Google Scholar
• Ferracioli-Oda E, Qawasmi A, Bloch MH. (2013). Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS ONE 8:e63773
   PubMed Web of Science ®Google Scholar
• Flohé L, Günzler WA. (1984). Assays of glutathione peroxidase. Meth Enzymol 105:114–21
   PubMed Web of Science ®Google Scholar
• Johansen JS, Harris AK, Rychly DJ, Ergul A. (2005). Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 4:5–9
   PubMed Web of Science ®Google Scholar
• Kedziora-Kornatowska K, Szewczyk-Golec K, Czuczejko J, et al. (2008). Antioxidative effects of melatonin administration in elderly primary essential hypertension patients. J Pineal Res 45:312–17
   PubMed Web of Science ®Google Scholar
• Kedziora-Kornatowska K, Szewczyk-Golec K, Kozakiewicz M, et al. (2009). Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients. J Pineal Res 46:333–7
   PubMed Web of Science ®Google Scholar
• Kupczyk D, Rybka J, Kedziora-Kornatowska K, Kedziora J. (2010). Melatonin and oxidative stress in elderly patients with type 2 diabetes. Pol Merkur Lekarski 28:407–9
   PubMedGoogle Scholar
• Loh K, Deng H, Fukushima A, et al. (2009). Reactive oxygen species enhance insulin sensitivity. Cell Metabol 10:260–72
   PubMed Web of Science ®Google Scholar
• Mayo JC, Sainz RM, Antoli I, et al. (2002). Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci 59:1706–13
   PubMed Web of Science ®Google Scholar
• Misra HP, Fridovich I. (1972). The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170–5
   PubMed Web of Science ®Google Scholar
• Mukherjee D, Roy SG, Bandyopadhyay A, et al. (2010). Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms. J Pineal Res 48:251–62
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentine WN. (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–69
   PubMed Web of Science ®Google Scholar
• Peschke E, Wolgast S, Bazwinsky I, et al. (2008). Increased melatonin synthesis in pineal glands of rats in streptozotocin induced type 1 diabetes. J Pineal Res 45:439–48
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan D, Terron MP, et al. (2007). Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 54:1–9
   PubMed Web of Science ®Google Scholar
• Rybka J, Kupczyk D, Kędziora-Kornatowska K, et al. (2011). Age-related changes in an antioxidant defense system in elderly patients with essential hypertension compared with healthy controls. Redox Rep 16:71–7
   PubMed Web of Science ®Google Scholar
• Simko F, Paulis L. (2007). Melatonin as a potential antihypertensive treatment. J Pineal Res 42:319–22
   PubMed Web of Science ®Google Scholar
• Stebelová K, Herichová I, Zeman M. (2007). Diabetes induces changes in melatonin concentrations in peripheral tissues of rat. Neuro Endocrinol Lett 28:159–65
   PubMed Web of Science ®Google Scholar
• Vijayalaxmi, Thomas CR Jr. (2002). Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 20:2575–601
   PubMed Web of Science ®Google Scholar
• Wade A, Downie S. (2008). Prolonged-release melatonin for the treatment of insomnia in patients over 55 years. Expert Opin Investig Drugs 17:1567–72
   PubMed Web of Science ®Google Scholar